A rating scale for dementia severity (Clinical Dementia Rating – Sum of Boxes, CDR-SB) used in patients with mild NCD showed a trend in favor of EGb 761, whereas an ADL scale for patients with MCI (Alzheimer’s Disease Cooperative Study ADL Scale for MCI, ADCS-ADL-MCI-24) showed a significant treatment effect of EGb 761.
← all excerpts
<i>Ginkgo biloba</i> Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
1
—
—